Zeen by Exokinetics

Zeen by Exokinetics

Growth Stage

Innovative mobility devices for those facing restrictions due to age or disability

Innovative mobility devices for those facing restrictions due to age or disability

Overview

Raised to Date:
$118,945 - RegCF
$218,944 - Total

Total Commitments ($USD)

Platform

SeedInvest

Start Date

09/25/2022

Close Date

01/31/2023

Min. Goal
$25,000
Max. Goal
$5,000,000
Min. Investment

$1,000

Security Type

Equity - Preferred

Series

Series B

SEC Filing Type

RegCF / RegD 506(c)    Open SEC Filing

Price Per Share

$1.21

Pre-Money Valuation

$25,000,000

Rolling Commitments ($USD)

Status
Not Funded
Reporting Date

02/04/2023

Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise

$937

Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2016

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2C

Margin

Low

Capital Intensity

High

Location

West Chester, Pennsylvania

Business Type

Growth

Zeen by Exokinetics, with a valuation of $25 million, is raising funds on SeedInvest. It is a new mobility device for those battling age, injury, and disease to enjoyably bridge sitting, standing, walking, and coasting. Zeen can lift patients up to a standing position and become a fast and safe way to move around or relax at a sociable height. Zeen by Exokinetics works on patented and differentiated technology and has received pre-orders surpassing the current manufacturing capabilities. Garrett Brown founded Zeen by Exokinetics in July 2016. The current crowdfunding campaign has a minimum RegCF target of $25,000, a minimum raise target of $1.9 million, and a maximum target of $5 million. The campaign proceeds will be used for inventory, payroll and planned hires, sales and marketing, product development, and general operations.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-2,262,253

$-1,628,356

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$594,820

$2,894,127

Accounts Receivable

$0

$0

Total Assets

$2,458,483

$3,667,223

Short-Term Debt

$107,749

$49,534

Long-Term Debt

$1,164,761

$111,249

Total Liabilities

$1,272,510

$160,783

Financials as of: 09/25/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Zeen by Exokinetics on SeedInvest 2022
Platform: SeedInvest
Security Type: Equity - Preferred
Valuation: $25,000,000
Price per Share: $1.21

Follow company

Follow Zeen by Exokinetics on SeedInvest 2022

Buy Zeen by Exokinetics's Deal Report

Warning: according to the close date for this deal, Zeen by Exokinetics may no longer be accepting investments.

Zeen by Exokinetics Deal Report

Get KingsCrowd’s comprehensive report on Zeen by Exokinetics including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Zeen by Exokinetics is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Zeen by Exokinetics deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge